<?xml version="1.0" encoding="UTF-8"?>
<p>The 8722 antiviral drugs and 265 FDA approved drugs used for infectious diseases were selected for virtual screening and molecular docking study against SARS-CoV-2 target proteins (6VYO) from Asinex Elite molecular database (
 <ext-link ext-link-type="uri" xlink:href="http://www.asinex.com/antiviral/" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.asinex.com/antiviral/</ext-link>) and NCBI PubChem database (
 <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/" xmlns:xlink="http://www.w3.org/1999/xlink">https://pubchem.ncbi.nlm.nih.gov/</ext-link>), respectively. The ligands were prepared by using the ligand preparation module of molecular modeling package with suitable parameters like optimization, ring conformation, 2D to 3D conversion, determination of promoters, tautomers and ionization states at pH 7.0 along with partial atomic charges using OPLS3e force field A.
</p>
